{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:59:33Z","timestamp":1771487973958,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,17]]},"DOI":"10.7759\/cureus.36306","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T19:58:50Z","timestamp":1679083130000},"source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Potential Drug-Drug Interactions Among Hypertensive Pregnant Women Admitted to a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Akshitha S","family":"Ragam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheela","family":"S R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Drug toxicity and poisoning","author":"Osterhoudt KC","year":"2015","unstructured":"Osterhoudt KC, Penning JC. Drug toxicity and poisoning. Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics.  Brunton LL, Chabner AB, Knollmann CB (ed): McGraw-Hill, New York, NY; 2015. 12:"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31815c16f5","article-title":"Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring","volume":"29","author":"Zhou SF","year":"2007","unstructured":"Zhou SF, Xue CC, Yu XQ, Li C, Wang G. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit. 2007, 29:687-710. 10.1097\/FTD.0b013e31815c16f5","journal-title":"Ther Drug Monit"},{"key":"ref3","article-title":"Pharmacokinetic drug-drug interaction and their implication in clinical management","volume":"18","author":"Palleria C","year":"2013","unstructured":"Palleria C, Di Paolo A, Giofr\u00e8 C, et al.. Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci. 2013, 18:601-10.","journal-title":"J Res Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1590\/s0104-11692009000200013","article-title":"Potential drug interactions in intensive care patients at a teaching hospital","volume":"17","author":"Lima RE","year":"2009","unstructured":"Lima RE, De Bortoli Cassiani SH. Potential drug interactions in intensive care patients at a teaching hospital. Rev Lat Am Enfermagem. 2009, 17:222-7. 10.1590\/s0104-11692009000200013","journal-title":"Rev Lat Am Enfermagem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1351","article-title":"Hospitalisations and emergency department visits due to drug-drug interactions: a literature review","volume":"16","author":"Becker ML","year":"2007","unstructured":"Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007, 16:641-51. 10.1002\/pds.1351","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref6","unstructured":"Preventable Adverse Drug Reactions. A Focus on Drug Interactions. (2023). Accessed: February 27, 2023: http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/DrugInteractionsLabeling\/ucm110632.htm."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine MM","year":"2014","unstructured":"Costantine MM. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014, 5:65. 10.3389\/fphar.2014.00065","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.9.824","article-title":"Postmarketing surveillance and adverse drug reactions: current perspectives and future needs","volume":"281","author":"Brewer T","year":"1999","unstructured":"Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA. 1999, 281:824-9. 10.1001\/jama.281.9.824","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000189","article-title":"Maternal critical care: 'one small step for woman, one giant leap for womankind'","volume":"28","author":"Patil V","year":"2015","unstructured":"Patil V, Jigajinni S, Wijayatilake DS. Maternal critical care: 'one small step for woman, one giant leap for womankind'. Curr Opin Anaesthesiol. 2015, 28:290-9. 10.1097\/ACO.0000000000000189","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1707-x","article-title":"Obstetric intensive care unit admission: a 2-year nationwide population-based cohort study","volume":"36","author":"Zwart JJ","year":"2010","unstructured":"Zwart JJ, Dupuis JR, Richters A, Ory F, van Roosmalen J. Obstetric intensive care unit admission: a 2-year nationwide population-based cohort study. Intensive Care Med. 2010, 36:256-63. 10.1007\/s00134-009-1707-x","journal-title":"Intensive Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2013.01.014","article-title":"The management of hypertension in pregnancy","volume":"20","author":"Kattah AG","year":"2013","unstructured":"Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013, 20:229-39. 10.1053\/j.ackd.2013.01.014","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-34","article-title":"An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management","volume":"13","author":"Smith JM","year":"2013","unstructured":"Smith JM, Lowe RF, Fullerton J, Currie SM, Harris L, Felker-Kantor E. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management. BMC Pregnancy Childbirth. 2013, 13:34. 10.1186\/1471-2393-13-34","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000117797","article-title":"Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait","volume":"17","author":"Omu AE","year":"2008","unstructured":"Omu AE, Al-Harmi J, Vedi HL, Mlechkova L, Sayed AF, Al-Ragum NS. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait. Med Princ Pract. 2008, 17:227-32. 10.1159\/000117797","journal-title":"Med Princ Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-195","article-title":"Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review","volume":"13","author":"Bain ES","year":"2013","unstructured":"Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy Childbirth. 2013, 13:195. 10.1186\/1471-2393-13-195","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181de0acf","article-title":"Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations","volume":"38","author":"Papadopoulos J","year":"2010","unstructured":"Papadopoulos J, Smithburger PL. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations. Crit Care Med. 2010, 38:S126-35. 10.1097\/CCM.0b013e3181de0acf","journal-title":"Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010378858","article-title":"Incidence and contributors to potential drug-drug interactions in hospitalized patients","volume":"51","author":"Reimche L","year":"2011","unstructured":"Reimche L, Forster AJ, van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol. 2011, 51:1043-50. 10.1177\/0091270010378858","journal-title":"J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/beog.2001.0232","article-title":"Drugs in pregnancy. Antihypertensives","volume":"15","author":"Magee LA","year":"2001","unstructured":"Magee LA. Drugs in pregnancy. Antihypertensives. Best Pract Res Clin Obstet Gynaecol. 2001, 15:827-45. 10.1053\/beog.2001.0232","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref18","article-title":"Impact of pharmacists\u2019 intervention on identification and management of drug-drug interactions in an intensive care setting","volume":"53","author":"Hasan SS","year":"2012","unstructured":"Hasan SS, Lim KN, Anwar M, et al.. Impact of pharmacists\u2019 intervention on identification and management of drug-drug interactions in an intensive care setting. Singap Med J. 2012, 53:526-31.","journal-title":"Singap Med J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.84597","article-title":"Prospective observational evaluation of incidences and implications of drug-drug interactions induced adverse drug reactions in critically ill patients","volume":"72","author":"Ray S","year":"2010","unstructured":"Ray S, Pramanik J, Bhattacharyya M, Todi S. Prospective observational evaluation of incidences and implications of drug-drug interactions induced adverse drug reactions in critically ill patients. Indian J Pharm Sci. 2010, 72:787-92. 10.4103\/0250-474X.84597","journal-title":"Indian J Pharm Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0976-0105.134983","article-title":"A study of potential adverse drug-drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital","volume":"5","author":"Patel PS","year":"2014","unstructured":"Patel PS, Rana DA, Suthar JV, Malhotra SD, Patel VJ. A study of potential adverse drug-drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital. J Basic Clin Pharm. 2014, 5:44-8. 10.4103\/0976-0105.134983","journal-title":"J Basic Clin Pharm"},{"key":"ref21","article-title":"Assessment of potential drug-drug interactions among outpatients receiving cardiovascular medications at Jimma University specialized hospital, South West Ethiopia","volume":"2","author":"Chelkeba L","year":"2017","unstructured":"Chelkeba L, Alemseged F, Bedada W. Assessment of potential drug-drug interactions among outpatients receiving cardiovascular medications at Jimma University specialized hospital, South West Ethiopia. Int J Basic Clin Pharmacol. 2017, 2:144-52.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2019AO4521","article-title":"Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications","volume":"17","author":"Pessoa TL","year":"2019","unstructured":"Pessoa TL, Clemente Junior WS, Costa TX, Bezerra PK, Martins RR. Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications. Einstein (Sao Paulo). 2019, 17:eAO4521. 10.31744\/einstein_journal\/2019AO4521","journal-title":"Einstein (Sao Paulo)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-289x(98)80047-2","article-title":"Cardiovascular consequences of the concomitant administration of nifedipine and magnesium sulfate in pigs","volume":"7","author":"Neustein S","year":"1998","unstructured":"Neustein S, Dimich I, Shiang H, et al.. Cardiovascular consequences of the concomitant administration of nifedipine and magnesium sulfate in pigs. Int J Obstet Anesth. 1998, 7:247-50. 10.1016\/s0959-289x(98)80047-2","journal-title":"Int J Obstet Anesth"},{"key":"ref24","article-title":"Healthcare Series","author":"MICROMEDEXTM","year":"2011","unstructured":"MICROMEDEXTM. Healthcare Series. Thomson Reuters, Greenwood Village; 2011."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142268-prevalence-of-potential-drug-drug-interactions-among-hypertensive-pregnant-women-admitted-to-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:06Z","timestamp":1707508506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142268-prevalence-of-potential-drug-drug-interactions-among-hypertensive-pregnant-women-admitted-to-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.36306","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}